Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse

Research output: Contribution to journalPublished meeting abstract

Details

Authors
  • Mark Levis
  • Farhad Ravandi
  • Eunice S. Wang
  • Maria R. Baer
  • Alexander Perl
  • Steven Coutre
  • Harry Erba
  • Robert K. Stuart
  • Michele Baccarani
  • Larry D. Cripe
  • Martin S. Tallman
  • Giovanna Meloni
  • Lucy A. Godley
  • Amelia A. Langston
  • Sergio Amadori
  • Ian D. Lewis
  • Arnon Nagler
  • Richard Stone
  • Karen Yee
  • Anjali Advani
  • Dan Douer
  • Wieslaw W. Jedrzejczak
  • Mark R. Litzow
  • Stephen Petersdorf
  • Miguel Sanz
  • Hagop M. Kantarjian
  • Takashi Sato
  • Lothar Tremmel
  • Debra M. Bensen-Kennedy
  • Donald Small
  • B. Douglas Smith
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Hematology
Original languageEnglish
Pages (from-to)325-326
JournalBlood
Volume114
Issue number22
Publication statusPublished - 2009
Publication categoryResearch
Peer-reviewedYes
Event51st Annual Meeting of the American-Society-of-Hematology - New Orleans, LA
Duration: 2009 Dec 52009 Dec 8